Thursday, February 24, 2022

OptimizeRx: Revenue Increased 42%, Demand from Large Pharma Gains Momentum

 

  • Fourth quarter revenue Up 24% to $20.3 million, gross profit margin of 61%

  • Introduction of key performance indicators (KPIs) representing “land and expand” strategy with key customer accounts

  • Cash flow positive from operations of $0.7 million in 2021

at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.